The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making

Real‐world data (RWD) and real‐world evidence (RWE) are becoming essential tools for informing regulatory decision making in health care and offer an opportunity for all stakeholders in the healthcare ecosystem to evaluate medical products throughout their lifecycle. Although considerable interest h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacology and therapeutics 2022-12, Vol.112 (6), p.1172-1182
Hauptverfasser: Baumfeld Andre, Elodie, Carrington, Nate, Siami, Flora S., Hiatt, Jo Carol, McWilliams, Carly, Hiller, Carolyn, Surinach, Andy, Zamorano, Alejandro, Pashos, Chris L., Schulz, Wade L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1182
container_issue 6
container_start_page 1172
container_title Clinical pharmacology and therapeutics
container_volume 112
creator Baumfeld Andre, Elodie
Carrington, Nate
Siami, Flora S.
Hiatt, Jo Carol
McWilliams, Carly
Hiller, Carolyn
Surinach, Andy
Zamorano, Alejandro
Pashos, Chris L.
Schulz, Wade L.
description Real‐world data (RWD) and real‐world evidence (RWE) are becoming essential tools for informing regulatory decision making in health care and offer an opportunity for all stakeholders in the healthcare ecosystem to evaluate medical products throughout their lifecycle. Although considerable interest has been given to regulatory decisions supported by RWE for treatment authorization, especially in rare diseases, less attention has been given to RWD/RWE related to in vitro diagnostic (IVD) products and clinical decision support systems (CDSS). This review examines current regulatory practices in relation to IVD product development and discusses the use of CDSS in assisting clinicians to retrieve, filter, and analyze patient data in support of complex decisions regarding diagnosis and treatment. The review then explores how utilizing RWD could augment regulatory body understanding of test performance, clinical outcomes, and benefit‐risk profiles, and how RWD could be leveraged to augment CDSS and improve safety, quality, and efficiency of healthcare practices. Whereas we present examples of RWD assisting in the regulation of IVDs and CDSS, we also highlight key challenges within the current healthcare system which are impeding the potential of RWE to be fully realized. These challenges include issues such as data availability, reliability, accessibility, harmonization, and interoperability, often for reasons specific to diagnostics. Finally, we review ways that these challenges are actively being addressed and discuss how private‐public collaborations and the implementation of standardized language and protocols are working toward producing more robust RWD and RWE to support regulatory decision making.
doi_str_mv 10.1002/cpt.2565
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9790425</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2633850825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4105-48129fbb38361ead07e750070fd4a203d4a2d87df8864c55c0a6d52d872637763</originalsourceid><addsrcrecordid>eNp1UUtu1DAYthCIDgWJEyAv2aT4ESfOBqnKFKg0qKgMYml5HCc1OHZqO6DZcQRu0Lv1JHimD8qCje3f38vyB8BLjI4wQuSNmtIRYRV7BBaYUVJUjLLHYIEQaoqG0OoAPIvxWx7LhvOn4IAygmld4gW4Wl9o2M4haJfgSrouKjlpmA_wZNRhMG6Ax9NkjZLJeBdh7wM819Je__r91QfbwaVMEhoHl0YOzsdkVNzLW2tcVlm41MrErIWf52nyIe1RkyI8HSepEszIuR5mK5MP27_sj_J7Dn8OnvTSRv3idj8EX96drNsPxers_Wl7vCpUiRErSo5J0282lNMKa9mhWtcMoRr1XSkJoru143XXc16VijGFZNWx3RWpaF1X9BC8vfGd5s2oO5W_I0grpmBGGbbCSyP-RZy5EIP_IZq6QSVh2eD1rUHwl7OOSYwmKm2tdNrPUeQcyhniD6kq-BiD7u9jMBK7PkXuU-z6zNRXD591T7wrMBOKG8JPY_X2v0ai_bTeG_4B-2KtBQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2633850825</pqid></control><display><type>article</type><title>The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Baumfeld Andre, Elodie ; Carrington, Nate ; Siami, Flora S. ; Hiatt, Jo Carol ; McWilliams, Carly ; Hiller, Carolyn ; Surinach, Andy ; Zamorano, Alejandro ; Pashos, Chris L. ; Schulz, Wade L.</creator><creatorcontrib>Baumfeld Andre, Elodie ; Carrington, Nate ; Siami, Flora S. ; Hiatt, Jo Carol ; McWilliams, Carly ; Hiller, Carolyn ; Surinach, Andy ; Zamorano, Alejandro ; Pashos, Chris L. ; Schulz, Wade L.</creatorcontrib><description>Real‐world data (RWD) and real‐world evidence (RWE) are becoming essential tools for informing regulatory decision making in health care and offer an opportunity for all stakeholders in the healthcare ecosystem to evaluate medical products throughout their lifecycle. Although considerable interest has been given to regulatory decisions supported by RWE for treatment authorization, especially in rare diseases, less attention has been given to RWD/RWE related to in vitro diagnostic (IVD) products and clinical decision support systems (CDSS). This review examines current regulatory practices in relation to IVD product development and discusses the use of CDSS in assisting clinicians to retrieve, filter, and analyze patient data in support of complex decisions regarding diagnosis and treatment. The review then explores how utilizing RWD could augment regulatory body understanding of test performance, clinical outcomes, and benefit‐risk profiles, and how RWD could be leveraged to augment CDSS and improve safety, quality, and efficiency of healthcare practices. Whereas we present examples of RWD assisting in the regulation of IVDs and CDSS, we also highlight key challenges within the current healthcare system which are impeding the potential of RWE to be fully realized. These challenges include issues such as data availability, reliability, accessibility, harmonization, and interoperability, often for reasons specific to diagnostics. Finally, we review ways that these challenges are actively being addressed and discuss how private‐public collaborations and the implementation of standardized language and protocols are working toward producing more robust RWD and RWE to support regulatory decision making.</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1002/cpt.2565</identifier><identifier>PMID: 35213741</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>Decision Making ; Decision Support Systems, Clinical ; Ecosystem ; Humans ; Rare Diseases ; Reproducibility of Results ; Review ; Reviews</subject><ispartof>Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1172-1182</ispartof><rights>2022 Roche Diagnostics. published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.</rights><rights>2022 Roche Diagnostics. Clinical Pharmacology &amp; Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4105-48129fbb38361ead07e750070fd4a203d4a2d87df8864c55c0a6d52d872637763</citedby><cites>FETCH-LOGICAL-c4105-48129fbb38361ead07e750070fd4a203d4a2d87df8864c55c0a6d52d872637763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcpt.2565$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcpt.2565$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35213741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baumfeld Andre, Elodie</creatorcontrib><creatorcontrib>Carrington, Nate</creatorcontrib><creatorcontrib>Siami, Flora S.</creatorcontrib><creatorcontrib>Hiatt, Jo Carol</creatorcontrib><creatorcontrib>McWilliams, Carly</creatorcontrib><creatorcontrib>Hiller, Carolyn</creatorcontrib><creatorcontrib>Surinach, Andy</creatorcontrib><creatorcontrib>Zamorano, Alejandro</creatorcontrib><creatorcontrib>Pashos, Chris L.</creatorcontrib><creatorcontrib>Schulz, Wade L.</creatorcontrib><title>The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Real‐world data (RWD) and real‐world evidence (RWE) are becoming essential tools for informing regulatory decision making in health care and offer an opportunity for all stakeholders in the healthcare ecosystem to evaluate medical products throughout their lifecycle. Although considerable interest has been given to regulatory decisions supported by RWE for treatment authorization, especially in rare diseases, less attention has been given to RWD/RWE related to in vitro diagnostic (IVD) products and clinical decision support systems (CDSS). This review examines current regulatory practices in relation to IVD product development and discusses the use of CDSS in assisting clinicians to retrieve, filter, and analyze patient data in support of complex decisions regarding diagnosis and treatment. The review then explores how utilizing RWD could augment regulatory body understanding of test performance, clinical outcomes, and benefit‐risk profiles, and how RWD could be leveraged to augment CDSS and improve safety, quality, and efficiency of healthcare practices. Whereas we present examples of RWD assisting in the regulation of IVDs and CDSS, we also highlight key challenges within the current healthcare system which are impeding the potential of RWE to be fully realized. These challenges include issues such as data availability, reliability, accessibility, harmonization, and interoperability, often for reasons specific to diagnostics. Finally, we review ways that these challenges are actively being addressed and discuss how private‐public collaborations and the implementation of standardized language and protocols are working toward producing more robust RWD and RWE to support regulatory decision making.</description><subject>Decision Making</subject><subject>Decision Support Systems, Clinical</subject><subject>Ecosystem</subject><subject>Humans</subject><subject>Rare Diseases</subject><subject>Reproducibility of Results</subject><subject>Review</subject><subject>Reviews</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1UUtu1DAYthCIDgWJEyAv2aT4ESfOBqnKFKg0qKgMYml5HCc1OHZqO6DZcQRu0Lv1JHimD8qCje3f38vyB8BLjI4wQuSNmtIRYRV7BBaYUVJUjLLHYIEQaoqG0OoAPIvxWx7LhvOn4IAygmld4gW4Wl9o2M4haJfgSrouKjlpmA_wZNRhMG6Ax9NkjZLJeBdh7wM819Je__r91QfbwaVMEhoHl0YOzsdkVNzLW2tcVlm41MrErIWf52nyIe1RkyI8HSepEszIuR5mK5MP27_sj_J7Dn8OnvTSRv3idj8EX96drNsPxers_Wl7vCpUiRErSo5J0282lNMKa9mhWtcMoRr1XSkJoru143XXc16VijGFZNWx3RWpaF1X9BC8vfGd5s2oO5W_I0grpmBGGbbCSyP-RZy5EIP_IZq6QSVh2eD1rUHwl7OOSYwmKm2tdNrPUeQcyhniD6kq-BiD7u9jMBK7PkXuU-z6zNRXD591T7wrMBOKG8JPY_X2v0ai_bTeG_4B-2KtBQ</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Baumfeld Andre, Elodie</creator><creator>Carrington, Nate</creator><creator>Siami, Flora S.</creator><creator>Hiatt, Jo Carol</creator><creator>McWilliams, Carly</creator><creator>Hiller, Carolyn</creator><creator>Surinach, Andy</creator><creator>Zamorano, Alejandro</creator><creator>Pashos, Chris L.</creator><creator>Schulz, Wade L.</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202212</creationdate><title>The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making</title><author>Baumfeld Andre, Elodie ; Carrington, Nate ; Siami, Flora S. ; Hiatt, Jo Carol ; McWilliams, Carly ; Hiller, Carolyn ; Surinach, Andy ; Zamorano, Alejandro ; Pashos, Chris L. ; Schulz, Wade L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4105-48129fbb38361ead07e750070fd4a203d4a2d87df8864c55c0a6d52d872637763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Decision Making</topic><topic>Decision Support Systems, Clinical</topic><topic>Ecosystem</topic><topic>Humans</topic><topic>Rare Diseases</topic><topic>Reproducibility of Results</topic><topic>Review</topic><topic>Reviews</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baumfeld Andre, Elodie</creatorcontrib><creatorcontrib>Carrington, Nate</creatorcontrib><creatorcontrib>Siami, Flora S.</creatorcontrib><creatorcontrib>Hiatt, Jo Carol</creatorcontrib><creatorcontrib>McWilliams, Carly</creatorcontrib><creatorcontrib>Hiller, Carolyn</creatorcontrib><creatorcontrib>Surinach, Andy</creatorcontrib><creatorcontrib>Zamorano, Alejandro</creatorcontrib><creatorcontrib>Pashos, Chris L.</creatorcontrib><creatorcontrib>Schulz, Wade L.</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baumfeld Andre, Elodie</au><au>Carrington, Nate</au><au>Siami, Flora S.</au><au>Hiatt, Jo Carol</au><au>McWilliams, Carly</au><au>Hiller, Carolyn</au><au>Surinach, Andy</au><au>Zamorano, Alejandro</au><au>Pashos, Chris L.</au><au>Schulz, Wade L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2022-12</date><risdate>2022</risdate><volume>112</volume><issue>6</issue><spage>1172</spage><epage>1182</epage><pages>1172-1182</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><abstract>Real‐world data (RWD) and real‐world evidence (RWE) are becoming essential tools for informing regulatory decision making in health care and offer an opportunity for all stakeholders in the healthcare ecosystem to evaluate medical products throughout their lifecycle. Although considerable interest has been given to regulatory decisions supported by RWE for treatment authorization, especially in rare diseases, less attention has been given to RWD/RWE related to in vitro diagnostic (IVD) products and clinical decision support systems (CDSS). This review examines current regulatory practices in relation to IVD product development and discusses the use of CDSS in assisting clinicians to retrieve, filter, and analyze patient data in support of complex decisions regarding diagnosis and treatment. The review then explores how utilizing RWD could augment regulatory body understanding of test performance, clinical outcomes, and benefit‐risk profiles, and how RWD could be leveraged to augment CDSS and improve safety, quality, and efficiency of healthcare practices. Whereas we present examples of RWD assisting in the regulation of IVDs and CDSS, we also highlight key challenges within the current healthcare system which are impeding the potential of RWE to be fully realized. These challenges include issues such as data availability, reliability, accessibility, harmonization, and interoperability, often for reasons specific to diagnostics. Finally, we review ways that these challenges are actively being addressed and discuss how private‐public collaborations and the implementation of standardized language and protocols are working toward producing more robust RWD and RWE to support regulatory decision making.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>35213741</pmid><doi>10.1002/cpt.2565</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1172-1182
issn 0009-9236
1532-6535
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9790425
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects Decision Making
Decision Support Systems, Clinical
Ecosystem
Humans
Rare Diseases
Reproducibility of Results
Review
Reviews
title The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T08%3A18%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Current%20Landscape%20and%20Emerging%20Applications%20for%20Real%E2%80%90World%20Data%20in%20Diagnostics%20and%20Clinical%20Decision%20Support%20and%20its%20Impact%20on%20Regulatory%20Decision%20Making&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Baumfeld%20Andre,%20Elodie&rft.date=2022-12&rft.volume=112&rft.issue=6&rft.spage=1172&rft.epage=1182&rft.pages=1172-1182&rft.issn=0009-9236&rft.eissn=1532-6535&rft_id=info:doi/10.1002/cpt.2565&rft_dat=%3Cproquest_pubme%3E2633850825%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2633850825&rft_id=info:pmid/35213741&rfr_iscdi=true